IL6 and rheumatoid arthritis: Similar to a previous finding, our results showed that the oral administration of DXM caused a dose-dependent decrease in the expression of TNF-α, IL-6 and IL-17 in arthritic paw tissues and in the sera of CIA mice and patients with RA.